Routine filing - Confirmation of share dematerialisation for Sep 2026 quarter
FREDUN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 1.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Fredun Pharmaceuticals filed a routine SEBI compliance certificate (Regulation 74(5)) from its Registrar Purva Sharegistry for the quarter ended September 30, 2026. It confirms share certificates received for dematerialisation were processed, securities were listed on the stock exchanges, and old physical certificates were mutilated and cancelled. The filing includes a long list of hundreds of shareholders whose physical shares were converted to electronic (demat) form, mostly dated July 17, 2026.
No material impact. Routine quarterly compliance confirming processing of share certificate conversions from physical to electronic form.